TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-47.31%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Cash on Hand
Cash on Hand as of September 2023 : $10.16 M
According to TherapeuticsMD's latest financial reports the company has $10.16 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
TherapeuticsMD - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $38.06 M | -41.35% |
| 2021-12-31 | $64.9 M | -19.36% |
| 2020-12-31 | $80.48 M | -49.96% |
| 2019-12-31 | $0.16 B | -0.48% |
| 2018-12-31 | $0.16 B | 27.12% |
| 2017-12-31 | $0.12 B | -3.34% |
| 2016-12-31 | $0.13 B | 103.28% |
| 2015-12-31 | $64.7 M | 25.98% |
| 2014-12-31 | $51.36 M | -5.22% |
| 2013-12-31 | $54.19 M | 3388.39% |
| 2012-12-31 | $1.55 M | 1128.81% |
| 2011-12-31 | $0.12 M | -70.11% |
| 2010-12-31 | $0.42 M | 905.42% |
| 2009-12-31 | $0.04 M | -22.7% |
| 2008-12-31 | $0.05 M | -86.68% |
| 2007-12-31 | $0.4 M | -58.54% |
| 2006-12-31 | $0.98 M | 9.25% |
| 2005-12-31 | $0.9 M | 250.16% |
| 2004-12-31 | $0.25 M | -8.1% |
| 2003-12-31 | $0.28 M | -25.83% |
| 2002-12-31 | $0.37 M | 10.06% |
| 2001-12-31 | $0.34 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 124,727.86% | 🇺🇸 USA |
 AbbVie ABBV | $12.81 B | 125,967.28% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.87 M | -71.74% | 🇺🇸 USA |
 Royalty Pharma RPRX | $1.23 B | 12,036.04% | 🇬🇧 UK |
 Lannett Company LCI | $46.54 M | 357.80% | 🇺🇸 USA |